课题基金 / 基金详情

项目摘要

项目成果

JOEL N BLANKSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Two mRNA COVID vaccines that have greater than 90% efficacy in healthy donors have been developed. However the efficacy of these vaccines in PLWH is unknown. PLWH have had suboptimal responses to some prior vaccines potentially because they make limited naïve T cell responses. We and others have shown T cell cross-recognition of spike proteins from SARS-CoV-2 and the common cold coronavirus and demonstrated that these cross-reactive responses are less effective against SARS-CoV-2 than mono- reactive responses. We hypothesize that cross-reactive memory responses will contribute more towards the total SARS-CoV-2 responses in PLWH than in healthy donors and this will result in less effective responses to the mRNA vaccines. We will test this hypothesis by comparing CD4+ T cell and antibody responses in vaccinated healthy donors and PLWH. Our results will have major implications for future policies regarding booster shots for PLWH and the general population
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Eradication of clonally expanded CD4+ T cells
  • 批准号:
    10621808
  • 项目类别:
  • 资助金额:
    $20.47万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
Eradication of clonally expanded CD4+ T cells
  • 批准号:
    10548015
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
mRNA vaccine responses in PLWH
  • 批准号:
    10402541
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
Optimization of high throughput viral outgrowth assays for the detection of HIV-1 reservoirs
  • 批准号:
    10177855
  • 项目类别:
  • 资助金额:
    $40.94万
  • 财政年份:
    2018
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
海外基金